Aguirre-Ruiz, P.; Ariceta, B.; Viguria, M.C.; Zudaire, M.T.; Blasco-Iturri, Z.; Arnedo, P.; Aguilera-Diaz, A.; Jauregui, A.; Mañú, A.; Prosper, F.;
et al. Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms. J. Clin. Med. 2020, 9, 3818.
https://doi.org/10.3390/jcm9123818
AMA Style
Aguirre-Ruiz P, Ariceta B, Viguria MC, Zudaire MT, Blasco-Iturri Z, Arnedo P, Aguilera-Diaz A, Jauregui A, Mañú A, Prosper F,
et al. Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms. Journal of Clinical Medicine. 2020; 9(12):3818.
https://doi.org/10.3390/jcm9123818
Chicago/Turabian Style
Aguirre-Ruiz, Paula, Beñat Ariceta, MarÃa Cruz Viguria, MarÃa Teresa Zudaire, Zuriñe Blasco-Iturri, Patricia Arnedo, Almudena Aguilera-Diaz, Axier Jauregui, Amagoia Mañú, Felipe Prosper,
and et al. 2020. "Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms" Journal of Clinical Medicine 9, no. 12: 3818.
https://doi.org/10.3390/jcm9123818
APA Style
Aguirre-Ruiz, P., Ariceta, B., Viguria, M. C., Zudaire, M. T., Blasco-Iturri, Z., Arnedo, P., Aguilera-Diaz, A., Jauregui, A., Mañú, A., Prosper, F., Mateos, M. C., Fernández-Mercado, M., Larráyoz, M. J., Redondo, M., Calasanz, M. J., Vázquez, I., & Bandrés, E.
(2020). Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms. Journal of Clinical Medicine, 9(12), 3818.
https://doi.org/10.3390/jcm9123818
